Malta Looks For European Action On Medicines Price Transparency 02/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Malta is working with Italy and 8 other European countries to lay the groundwork for a formal European Union framework in which members could voluntarily share information about medicines prices, in order to advance more coherent pricing policies in regional markets, Malta’s Deputy Prime Minister and Health Minister said on Wednesday. […] Continue reading -> Life Expectancy At All Time High In The Russian Federation Thanks To Alcohol Regulations 02/10/2019 Grace Ren Life expectancy increased to a historic peak of 68 years for men and 78 years for women in the Russian Federation in 2018 thanks in part to stringent alcohol regulations. A new study published by the World Health Organization’s European Regional Office found that alcohol regulations in the country reduced consumption by more than 40% […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Belgium’s Hans Kluge Nominated As WHO European Regional Director 17/09/2019 Editorial team Hans Kluge, director of Health Systems and Public Health in WHO’s European Regional Office, has been nominated to become WHO/Europe’s next Regional Director (RD). Kluge, proposed by Belgium, was selected Tuesday by WHO’s 53 European member states out of a field of six candidates in a secret ballot during the WHO Regional Committee for Europe […] Continue reading -> Health Equity Stagnant Or Declining Across Europe, New WHO Report Finds 11/09/2019 Grace Ren Health equity in Europe has stagnated over the past decade, and in some case there are indications of a decline, a first-ever WHO report finds. However, advancing Universal Health Coverage (UHC) along with more inclusive policies for social welfare protection and political participation could put things back on track again. The Health Equity Status Report […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Life Expectancy At All Time High In The Russian Federation Thanks To Alcohol Regulations 02/10/2019 Grace Ren Life expectancy increased to a historic peak of 68 years for men and 78 years for women in the Russian Federation in 2018 thanks in part to stringent alcohol regulations. A new study published by the World Health Organization’s European Regional Office found that alcohol regulations in the country reduced consumption by more than 40% […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Belgium’s Hans Kluge Nominated As WHO European Regional Director 17/09/2019 Editorial team Hans Kluge, director of Health Systems and Public Health in WHO’s European Regional Office, has been nominated to become WHO/Europe’s next Regional Director (RD). Kluge, proposed by Belgium, was selected Tuesday by WHO’s 53 European member states out of a field of six candidates in a secret ballot during the WHO Regional Committee for Europe […] Continue reading -> Health Equity Stagnant Or Declining Across Europe, New WHO Report Finds 11/09/2019 Grace Ren Health equity in Europe has stagnated over the past decade, and in some case there are indications of a decline, a first-ever WHO report finds. However, advancing Universal Health Coverage (UHC) along with more inclusive policies for social welfare protection and political participation could put things back on track again. The Health Equity Status Report […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Belgium’s Hans Kluge Nominated As WHO European Regional Director 17/09/2019 Editorial team Hans Kluge, director of Health Systems and Public Health in WHO’s European Regional Office, has been nominated to become WHO/Europe’s next Regional Director (RD). Kluge, proposed by Belgium, was selected Tuesday by WHO’s 53 European member states out of a field of six candidates in a secret ballot during the WHO Regional Committee for Europe […] Continue reading -> Health Equity Stagnant Or Declining Across Europe, New WHO Report Finds 11/09/2019 Grace Ren Health equity in Europe has stagnated over the past decade, and in some case there are indications of a decline, a first-ever WHO report finds. However, advancing Universal Health Coverage (UHC) along with more inclusive policies for social welfare protection and political participation could put things back on track again. The Health Equity Status Report […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Belgium’s Hans Kluge Nominated As WHO European Regional Director 17/09/2019 Editorial team Hans Kluge, director of Health Systems and Public Health in WHO’s European Regional Office, has been nominated to become WHO/Europe’s next Regional Director (RD). Kluge, proposed by Belgium, was selected Tuesday by WHO’s 53 European member states out of a field of six candidates in a secret ballot during the WHO Regional Committee for Europe […] Continue reading -> Health Equity Stagnant Or Declining Across Europe, New WHO Report Finds 11/09/2019 Grace Ren Health equity in Europe has stagnated over the past decade, and in some case there are indications of a decline, a first-ever WHO report finds. However, advancing Universal Health Coverage (UHC) along with more inclusive policies for social welfare protection and political participation could put things back on track again. The Health Equity Status Report […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health Equity Stagnant Or Declining Across Europe, New WHO Report Finds 11/09/2019 Grace Ren Health equity in Europe has stagnated over the past decade, and in some case there are indications of a decline, a first-ever WHO report finds. However, advancing Universal Health Coverage (UHC) along with more inclusive policies for social welfare protection and political participation could put things back on track again. The Health Equity Status Report […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Collaboration between France and WHO to realize the vision of the WHO Academy 12/06/2019 Editorial team [WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading -> Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Incentives For EU Pharmaceutical R&D – New Review 03/06/2019 Editorial team A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Posts navigation Older postsNewer posts